Delivery Order SPE2DB22D3501-SPE2DB24FUE50
- Not listed
- This is a firm fixed price delivery order for $13,846.57 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of 4,564,205,429 units of the pharmaceutical product Ondansetron ODT 4 mg tablet in 30-count packages. The delivery order has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $1,041.90, is for the supply of 4563311949 - Ondansetron ODT 4 mg Tablet 30s, with a completion date of January 12, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has received numerous federal contract awards to provide pharmaceutical products and medical supplies in support of DLA...
- This is a $1,456.80 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of Ondansetron ODT 4 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing pharmaceutical products and medical supplies to the DLA. This delivery order is part of a larger indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of 4,563,982,184 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, packaged in 30s. The delivery order has a ceiling value of $5,636.04 and an ultimate completion date of March 18, 2024. No set-aside designation was used. AmerisourceBergen Drug Corporation,...
- This is a $8,769.42 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4,564,233,461 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. This delivery order was awarded under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential total value of $999,999,999.00 and a performance...
- This is a $6,028.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4,565,617,751 units of Ondansetron ODT 4 mg tablets to support military treatment programs and facilities. The award has an ultimate completion date of August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,734.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 8 mg tablets. The contract has a completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,433,570 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet in 30-count packages. The $11,760.19 order has a completion date of January 25, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as a prime contractor, has extensive experience delivering pharmaceuticals, medical supplies,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,396.65 contract is for the supply of the medication Ondansetron ODT 4 mg Tablets in 30-count packages. The delivery order has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,155,075 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet in 30-count packages. The contract has a completion date of December 21, 2023 and a potential value of $4,456.67. No set-aside designation was used. Amerisourcebergen Drug Corporation, through its Corporate Office division, has a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUE50Delivery Order
This is a $4,343.90 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4563347257 - Ondansetron ODT 4 mg tablets in a 30-count package. The delivery order has a completion date of January 18, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in support of DLA Troop Support Medical programs. This delivery order was not set aside. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, with a potential value of $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 1/17/24 |